Insurers cautious as biotech reshapes equine breeding coverage
Equine insurers will not increase coverage limits for foals produced through embryo transfer or sperm injection despite rising veterinary costs. DUAL North America caps foal values at two to three times stud fees regardless of advanced breeding methods. Executive Vice President Jason Collier said genetic manipulation introduces unforeseen mutation risks that fall under existing policy exclusions for defects.
The company maintains a $15,000 major medical limit that has not changed despite rising treatment costs. Collier said this coverage was designed for serious conditions rather than minor injuries. Insurers adjust valuations only after horses reach yearling age and demonstrate performance.
Underwriters are adopting data analytics tools to evaluate risk, but formal actuarial training remains uncommon in the sector. Younger professionals bring stronger technical skills, though they must learn equine industry specifics. The company uses Power BI software for near-real-time book analysis while monitoring developments in artificial intelligence.
